NEW YORK , May 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI). Shareholders who purchased shares of TMCI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , May 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of BigBear.ai Holdings, Inc. (NYSE: BBAI). Shareholders who purchased shares of BBAI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , May 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Napco Security Technologies, Inc. (NASDAQ: NSSC). Shareholders who purchased shares of NSSC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , May 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zenas BioPharma, Inc. (NASDAQ: ZBIO). Shareholders who purchased shares of ZBIO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , May 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Avis Budget Group, Inc. (NASDAQ: CAR). Shareholders who purchased shares of CAR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , May 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Civitas Resources, Inc. (NYSE: CIVI). Shareholders who purchased shares of CIVI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , May 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. (NYSE: ABBV). Shareholders who purchased shares of ABBV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , May 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of NET Power, Inc. (NYSE: NPWR). Shareholders who purchased shares of NPWR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , May 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Viatris Inc. (NASDAQ: VTRS). Shareholders who purchased shares of VTRS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , May 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ibotta, Inc. (NYSE: IBTA). Shareholders who purchased shares of IBTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Blue Owl Capital Corporation is the second-largest business development company globally, with a diversified investment-grade portfolio and a strong credit profile. OBDC's stock offers a higher dividend yield than its history and trades at an -8.3% discount to its net asset value, making it an attractive investment opportunity. Despite dropping net interest margins, economic uncertainty drives up credit spreads, which could benefit yield profitability in the future.

Gold price drops 3% after U.S.–China tariff deal. Rising dollar and fading safe-haven demand push XAU/USD toward key 50-day moving average support at $3137.

Summary ⚈ Two U.S. lawmakers sold AbbVie shares shortly before Trump's drug price-cutting announcement, raising concerns about potential insider knowledge. ⚈ Trump's May 13 executive order targets up to 80% reductions in drug costs, directly impacting companies like AbbVie.

Equinor's diversified portfolio, including strong core oil operations and growing renewables, supports its ability to drive long-term shareholder returns despite geopolitical instability. The company reported $8.6 billion in operating income and $2.6 billion in net income for 1Q 2025, maintaining a single-digit P/E ratio. Equinor's commitment to shareholder returns is evident with a $9 billion capital distribution for 2025, combining a 6.5% dividend yield and buybacks.

Occidental Petroleum reported strong Q1 results. Acquisitions are made to improve results. However, benefits may take time to materialize. Effective management sets and often exceeds goals.

SAN DIEGO , May 12, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Civitas Resources, Inc. (NYSE: CIVI) securities between February 27, 2024 and February 24, 2025, both dates inclusive (the "Class Period"), have until July 1, 2025 to seek appointment as lead plaintiff of the Civitas Resources class action lawsuit. Captioned Lin v.

Walmart (WMT) is set to report results for the first quarter of its 2026 fiscal year early Thursday, with analysts bullish on the retail giant they see as a potential winner from continued tariff uncertainty.

Earnings releases led to a slump in Uber shares and a surge in Lyft shares last week. Outlook for both look decent.

Semiconductor fabrication equipment is crucial for future tech growth, including EVs and AI datacenters, which require increased production of specialized chips. Axcelis Technologies, despite a temporary dip in orders, is vital for global semiconductor production with its innovative ion implant systems. Axcelis shares have dropped from extremely overvalued in 2023 to undervalued territory in 2025, opening an attractive investment proposition, especially after Q1 earnings beat estimates.

NEW YORK, NY / ACCESS Newswire / May 12, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=147988&wire=1 or contact Joseph E. Levi, Esq.